Literature DB >> 3312409

Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection.

S Cayphas1, J Van Damme, A Vink, R J Simpson, A Billiau, J Van Snick.   

Abstract

We have recently purified and partially sequenced a new T cell-derived lymphokine with growth factor activity for B cell hybridomas and plasmacytomas, which we named interleukin HP1 (HP1). Here we show that, in response to viral infection or after treatment with poly(rI).poly(rC), L cells produce a factor that is capable of supporting the in vitro growth and survival of HP1-dependent cell lines. Serologic and structural evidence is presented in favor of the identity between the fibroblast factor and HP1, demonstrating that non-T cells can make HP1-related molecules.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312409

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence.

Authors:  Y H Zhang; J X Lin; J Vilcek
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

2.  Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis.

Authors:  P A Guerne; B L Zuraw; J H Vaughan; D A Carson; M Lotz
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Protective effect of a novel antibody against TLR2 on zymosan-induced acute peritonitis in NF-κB transgenic mice.

Authors:  Qingjun Pan; Jun Cai; Yanxia Peng; Haiyan Xiao; Lifang Zhang; Jinying Chen; Huafeng Liu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

4.  Autocrine regulation and experimental modulation of interleukin-6 expression by human pulmonary epithelial cells infected with respiratory syncytial virus.

Authors:  Z Jiang; M Kunimoto; J A Patel
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses.

Authors:  C Truyens; A Angelo-Barrios; F Torrico; J Van Damme; H Heremans; Y Carlier
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Experimental elimination of tumor necrosis factor in low-dose endotoxin models has variable effects on survival.

Authors:  A K Franks; K I Kujawa; L J Yaffe
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones.

Authors:  I Holt; M W Davie; I P Braidman; M J Marshall
Journal:  Calcif Tissue Int       Date:  1994-08       Impact factor: 4.333

8.  In vivo polyclonal B-lymphocyte activation elicited by murine viruses.

Authors:  J P Coutelier; P G Coulie; P Wauters; H Heremans; J T van der Logt
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

9.  T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor.

Authors:  C Uyttenhove; P G Coulie; J Van Snick
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Distinct requirements for IL-6 in polyclonal and specific Ig production induced by microorganisms.

Authors:  D Markine-Goriaynoff; T D Nguyen; G Bigaignon; J Van Snick; J P Coutelier
Journal:  Int Immunol       Date:  2001-09       Impact factor: 4.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.